Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2015, Article ID 812089, 10 pages
http://dx.doi.org/10.1155/2015/812089
Research Article

Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center

1Sarcoma Unit, Royal Marsden Hospital, London SW3 6JJ, UK
2Department of Histopathology, Royal Marsden Hospital, London SW3 6JJ, UK
3Clinical Cytogenetics, Royal Marsden Hospital, Sutton, Surrey SM2 5NG, UK

Received 11 October 2014; Revised 5 January 2015; Accepted 19 January 2015

Academic Editor: Irene Andrulis

Copyright © 2015 Khin Thway et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Khin Thway, Jayson Wang, John Swansbury, Toon Min, and Cyril Fisher, “Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center,” Sarcoma, vol. 2015, Article ID 812089, 10 pages, 2015. https://doi.org/10.1155/2015/812089.